---
title: "UBS Reaffirms Their Buy Rating on Akeso, Inc. (9926)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289649001.md"
description: "UBS analyst Chen Chen reaffirmed a Buy rating on Akeso, Inc. (9926) with an HK$185.50 price target in a June 11 report. Shares closed at HK$87.80. The analyst holds a 4-star rating with strong historical performance. Akeso maintains a Strong Buy consensus among analysts, with an average price target of HK$176.35."
datetime: "2026-06-13T00:27:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289649001.md)
  - [en](https://longbridge.com/en/news/289649001.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289649001.md)
---

# UBS Reaffirms Their Buy Rating on Akeso, Inc. (9926)

In a report released on June 11, Chen Chen from UBS maintained a Buy rating on Akeso, Inc., with a price target of HK$185.50. The company’s shares closed yesterday at HK$87.80.

### Introducing TipRanks MCP for Agents

-   Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
-   Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.

According to TipRanks, Chen is a 4-star analyst with an average return of 40.9% and a 62.50% success rate.

Akeso, Inc. has an analyst consensus of Strong Buy, with a price target consensus of HK$176.35.

### Related Stocks

- [09926.HK](https://longbridge.com/en/quote/09926.HK.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)

## Related News & Research

- [Akeso Launches HK$200 Million Share Purchase as Leadership Boosts Stakes](https://longbridge.com/en/news/289413457.md)
- [China’s NMPA approves Akeso’s gumokimab for plaque psoriasis](https://longbridge.com/en/news/289582499.md)
- [21:57 ETAkeso's Gumokimab (AK111, Anti-IL-17) Approved by NMPA for Moderate-to-Severe Plaque Psoriasis, Bolstering Its Autoimmune Disease Portfolio](https://longbridge.com/en/news/289535144.md)
- [HSBC Sticks to Its Buy Rating for Pacific Basin Shipping (PCFBF)](https://longbridge.com/en/news/289533155.md)
- [HSBC Keeps Their Buy Rating on Geely Automobile Holdings (GELYF)](https://longbridge.com/en/news/289649252.md)